Citation Impact
Citing Papers
Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
2012
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
2018 Standout
Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes
2017
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Colistinvs. the combination of colistin and rifampicin for the treatment of carbapenem-resistantAcinetobacter baumanniiventilator-associated pneumonia
2012
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Molecular mechanisms of antibiotic resistance
2014 Standout
Treatment of Infections Due to MDR Gram-Negative Bacteria
2019
Prevalence and hazardous impact of pharmaceutical and personal care products and antibiotics in environment: A review on emerging contaminants
2021 Standout
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
2014 Standout
Treating infections caused by carbapenemase-producing Enterobacteriaceae
2014
Carbapenem-Resistant Enterobacterales: Considerations for Treatment in the Era of New Antimicrobials and Evolving Enzymology
2020
Frontline antibiotic therapy
2013
Environmental factors influencing the development and spread of antibiotic resistance
2017 Standout
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
2012
Carbapenem-Resistant Enterobacteriaceae Infections in Children
2015
Prevention of Venous Thromboembolism
2004 Standout
Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes
2013
Management of Urinary Tract Infections From Multidrug-Resistant Organisms
2013
Colistin: an update on the antibiotic of the 21st century
2012
Tackling antibiotic resistance: the environmental framework
2015 Standout
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options
2017
<p>Antimicrobial Resistance: Implications and Costs</p>
2019 Standout
Microbiota Modulation of the Gut-Lung Axis in COVID-19
2021 Standout
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
2015 Standout
Colistin in Pig Production: Chemistry, Mechanism of Antibacterial Action, Microbial Resistance Emergence, and One Health Perspectives
2016
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
2014
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
In Vitro Activity of Telavancin in Combination with Colistin versus Gram-Negative Bacterial Pathogens
2012
Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions
2012
Acinetobacter baumannii Resistance: A Real Challenge for Clinicians
2020
Antibiotic effectiveness: Balancing conservation against innovation
2014 Science
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Acinetobacter baumannii: Evolution of Antimicrobial Resistance—Treatment Options
2015
Bacterial Antibiotic Resistance: The Most Critical Pathogens
2021 Standout
Deep vein thrombosis: prophylaxis in acute spinal cord injured patients.
1988
Emergence of OXA-48 and OXA-181 Carbapenemases among Enterobacteriaceae in South Africa and Evidence of In Vivo Selection of Colistin Resistance as a Consequence of Selective Decontamination of the Gastrointestinal Tract
2012
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
2015
How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients
2018
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing
2020 Standout
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
2017 Standout
The global epidemiology of carbapenemase-producing Enterobacteriaceae
2016 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Works of Jovan Jacob being referenced
Pharmacokinetics of four different brands of colistimethate and formed colistin in rats
2013
Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
2013
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
2011
Synergistic Killing of Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula by Colistin Combined with Doripenem in an In Vitro Pharmacokinetic/Pharmacodynamic Model
2011